CD34 and Miyoshi myopathy: A meta-analysis including both prospective and retrospective studies suggested that cyclophosphamide 1–g/m2 plus G-CSF (RD or SD) is associated with significantly higher CD34+ cells yield in patients with MM when compared with G-CSF alone, which is consistent with our results [72].